English | 繁體

Search in the results

UM

Browse/Search Results:  1-7 of 7 Help

Selected(0)Clear Items/Page:    Sort:
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives Journal article
Ye,Zi Han, Yu,Wei Bang, Huang,Mu Yang, Chen,Jun, Lu,Jin Jian. Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives[J]. Acta Pharmaceutica Sinica B, 2023, 13(4), 1467-1487.
Authors:  Ye,Zi Han;  Yu,Wei Bang;  Huang,Mu Yang;  Chen,Jun;  Lu,Jin Jian
Favorite | TC[WOS]:9 TC[Scopus]:10  IF:14.7/14.1 | Submit date：2023/08/03
Bispecific Antibodies  Cancer  Cd47  Clinical Data  Combination Strategies  Future Perspectives  Mechanisms  Preclinical Data  
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives Review article
2023
Authors:  Ye, Zi Han;  Yu, Wei Bang;  Huang, Mu Yang;  Chen, Jun;  Lu, Jin Jian
Favorite | TC[WOS]:9 TC[Scopus]:10  IF:14.7/14.1 | Submit date：2023/05/02
Bispecific Antibodies  Cancer  Cd47  Clinical Data  Combination Strategies  Future Perspectives  Mechanisms  Preclinical Data  
CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer Journal article
Wei-Bang Yu, Yu-Chi Chen,, Can-Yu Huang, Zi-Han Ye, Wei Shi, Hong Zhu, Jia-Jie Shi, Jun Chen, Jin-Jian Lu. CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer[J]. Frontiers of Medicine, 2022, 17(1), 105-118.
Authors:  Wei-Bang Yu;  Yu-Chi Chen,;  Can-Yu Huang;  Zi-Han Ye;  Wei Shi; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:3.9/5.4 | Submit date：2023/01/30
Adcp  Anti-cd47 Antibody  Combination Strategy  Egfr  Osimertinib  
Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and in vitro Studies Journal article
Shi, Wei, Qi, Lu, You, Xiong Bin, Chen, Yu Chi, Xu, Yu Lian, Yu, Wei Bang, Huang, Mu Yang, Zhao, Hong, Lu, Jin Jian. Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and in vitro Studies[J]. Current Cancer Drug Targets, 2022, 22(2), 142-152.
Authors:  Shi, Wei;  Qi, Lu;  You, Xiong Bin;  Chen, Yu Chi;  Xu, Yu Lian; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:2.3/3.1 | Submit date：2022/06/14
Ahsa1  Breast Cancer  Invasion  Migration  Network Pharmacology  Shenling Baizhu Powder  
Regulation of CD47 expression by interferon-gamma in cancer cells Journal article
Ye, Zi Han, Jiang, Xiao Ming, Huang, Mu Yang, Xu, Yu Lian, Chen, Yu Chi, Yuan, Luo Wei, Huang, Can Yu, Yu, Wei Bang, Chen, Xiuping, Lu, Jin Jian. Regulation of CD47 expression by interferon-gamma in cancer cells[J]. Translational Oncology, 2021, 14(9), 101162.
Authors:  Ye, Zi Han;  Jiang, Xiao Ming;  Huang, Mu Yang;  Xu, Yu Lian;  Chen, Yu Chi; et al.
Favorite | TC[WOS]:15 TC[Scopus]:19  IF:4.5/4.2 | Submit date：2021/12/08
The development of small-molecule inhibitors targeting CD47 Journal article
Yu,Wei Bang, Ye,Zi Han, Chen,Xiuping, Shi,Jia Jie, Lu,Jin Jian. The development of small-molecule inhibitors targeting CD47[J]. Drug Discovery Today, 2021, 26(2), 561-568.
Authors:  Yu,Wei Bang;  Ye,Zi Han;  Chen,Xiuping;  Shi,Jia Jie;  Lu,Jin Jian
Favorite | TC[WOS]:47 TC[Scopus]:48  IF:6.5/7.3 | Submit date：2021/03/01
Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells Journal article
Yuan,Luo Wei, Jiang,Xiao Ming, Xu,Yu Lian, Huang,Mu Yang, Chen,Yu Chi, Yu,Wei Bang, Su,Min Xia, Ye,Zi Han, Chen,Xiuping, Wang,Yitao, Lu,Jin Jian. Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells[J]. Phytomedicine, 2021, 80(153394).
Authors:  Yuan,Luo Wei;  Jiang,Xiao Ming;  Xu,Yu Lian;  Huang,Mu Yang;  Chen,Yu Chi; et al.
Favorite | TC[WOS]:33 TC[Scopus]:36  IF:6.7/6.2 | Submit date：2021/03/01
Pd-l1  Ifn-γ  Natural Products  Licochalcone a  Protein Synthesis Inhibitor  Ros